| NDC Code | 0591-3739-01 |
|---|
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-3739-01) |
|---|
| Product NDC | 0591-3739 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Hydromorphone Hydrochloride |
|---|
| Non-Proprietary Name | Hydromorphone Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140521 |
|---|
| End Marketing Date | 20191031 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA202144 |
|---|
| Manufacturer | Actavis Pharma, Inc. |
|---|
| Substance Name | HYDROMORPHONE HYDROCHLORIDE |
|---|
| Strength | 12 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
|---|
| DEA Schedule | CII |
|---|